Annual Drug Patent Expirations for PREZISTA
Prezista is a drug marketed by Janssen Prods
and is included in two NDAs. It is available from six suppliers. There are four patents protecting this drug and two Paragraph IV challenges.
The generic ingredient in PREZISTA is darunavir ethanolate. Six suppliers are listed for this compound. Additional details are available on the darunavir ethanolate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
You must log in to post a comment.